CN113874344B - 8,9-二氢大麻二酚化合物的用途 - Google Patents

8,9-二氢大麻二酚化合物的用途 Download PDF

Info

Publication number
CN113874344B
CN113874344B CN202080030186.9A CN202080030186A CN113874344B CN 113874344 B CN113874344 B CN 113874344B CN 202080030186 A CN202080030186 A CN 202080030186A CN 113874344 B CN113874344 B CN 113874344B
Authority
CN
China
Prior art keywords
alkyl
cbd
alkenyl
compound
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080030186.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN113874344A (zh
Inventor
M·马斯卡尔
N·舍甫琴科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD
Publication of CN113874344A publication Critical patent/CN113874344A/zh
Application granted granted Critical
Publication of CN113874344B publication Critical patent/CN113874344B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/26—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
CN202080030186.9A 2019-03-08 2020-03-09 8,9-二氢大麻二酚化合物的用途 Active CN113874344B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962815735P 2019-03-08 2019-03-08
US62/815,735 2019-03-08
PCT/US2020/021670 WO2020185661A1 (en) 2019-03-08 2020-03-09 Use of 8,9-dihydrocannabidiol compounds

Publications (2)

Publication Number Publication Date
CN113874344A CN113874344A (zh) 2021-12-31
CN113874344B true CN113874344B (zh) 2025-05-27

Family

ID=72426794

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080030186.9A Active CN113874344B (zh) 2019-03-08 2020-03-09 8,9-二氢大麻二酚化合物的用途

Country Status (8)

Country Link
US (1) US20250152520A2 (https=)
EP (1) EP3935037A4 (https=)
JP (1) JP7620984B2 (https=)
CN (1) CN113874344B (https=)
AU (1) AU2020236953A1 (https=)
BR (1) BR112021017661A2 (https=)
CA (1) CA3132841A1 (https=)
WO (1) WO2020185661A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021150885A1 (en) * 2020-01-24 2021-07-29 Perkinelmer Health Sciences, Inc. Cannabinoid derivatives
CN114507153B (zh) * 2020-11-17 2025-06-24 中国科学院上海药物研究所 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用
CN113372196B (zh) * 2021-07-02 2022-09-30 江南大学 8,9-二氢大麻二酚及其合成方法与应用
WO2024006896A1 (en) * 2022-06-29 2024-01-04 The Regents Of The University Of California Uses of hydrogenated cannabidiol (h4cbd) and advanced metabolic syndrome
AU2024359022A1 (en) * 2023-10-10 2026-04-09 Jazz Pharmaceuticals Research Uk Limited Cannabinoid compounds and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018777A (en) * 1975-11-14 1977-04-19 Abbott Laboratories 2-Substituted-5-alkyl resorcinols
CN108785298A (zh) * 2017-04-27 2018-11-13 汉义生物科技（北京）有限公司 一种用于治疗癫痫的药物组合物、其制备方法及用途
CN109106699A (zh) * 2017-06-23 2019-01-01 汉义生物科技（北京）有限公司 一种用于治疗癫痫的药物组合物、其制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI583374B (zh) 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
GB2530001B (en) * 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
CN108024973A (zh) * 2015-07-16 2018-05-11 耶路撒冷希伯来大学伊森姆研究发展有限公司 氟化的cbd化合物、其组合物以及用途

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018777A (en) * 1975-11-14 1977-04-19 Abbott Laboratories 2-Substituted-5-alkyl resorcinols
CN108785298A (zh) * 2017-04-27 2018-11-13 汉义生物科技（北京）有限公司 一种用于治疗癫痫的药物组合物、其制备方法及用途
CN109106699A (zh) * 2017-06-23 2019-01-01 汉义生物科技（北京）有限公司 一种用于治疗癫痫的药物组合物、其制备方法及用途

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Synthesis and Pharmacological Evaluation in Mice of Halogenated Cannabidiol Derivatives";Noriyuki Usami等;《Chem. Pharm.Bull.》;第47卷(第11期);第1641-1645页 *
"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome";Orrin Devinsky等;《The New England Journal of Medicine》;第376卷(第21期);第2011-2020页 *
Mark Mascal等."synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures".《Scientific Reports》.2019,第9卷(第1期),第1-6页. *

Also Published As

Publication number Publication date
US20250152520A2 (en) 2025-05-15
JP7620984B2 (ja) 2025-01-24
EP3935037A4 (en) 2023-03-22
BR112021017661A2 (pt) 2021-11-16
JP2022525038A (ja) 2022-05-11
US20220183998A1 (en) 2022-06-16
AU2020236953A1 (en) 2021-09-30
WO2020185661A1 (en) 2020-09-17
EP3935037A1 (en) 2022-01-12
CA3132841A1 (en) 2020-09-17
CN113874344A (zh) 2021-12-31

Similar Documents

Publication Publication Date Title
CN113874344B (zh) 8,9-二氢大麻二酚化合物的用途
US12534438B2 (en) Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
US11685739B2 (en) High penetration drugs and their compositions thereof for treatment of Parkinson diseases
ES2716832T3 (es) Compuestos carbamatos de fenilo para su uso en el alivio o el tratamiento del dolor y el dolor neuropático
US20240254072A1 (en) Derivatives of cannabidiol-c4 for the treatment of epilepsy
Bai et al. Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases
ES2881850T3 (es) Compuestos de carmato de fenil alquilo para su uso en la prevención o tratamiento de la epilepsia o síndrome relacionado con la epilepsia
EP2242492B1 (en) Antitumoral agents with a benzophenanthridine structure and formulations containing them
JP2007510737A (ja) 癌処置のためのセラミド異化阻害剤としてのｐｐｍｐ
US5962523A (en) Methods of using butyric acid derivatives to protect against hair loss
US9802962B2 (en) Tricyclic pyrone compounds reduce amyloid beta aggregates
US20170151337A1 (en) High penetration composition and uses thereof
JP2021533115A (ja) 神経疾患またはミトコンドリア疾患の処置のための化合物
US20130101527A1 (en) Methods, compounds and pharmaceutical compositions for treating neurological disorders
US20250009766A1 (en) Cannabigerol for treatment of seizures and epilepsy
CN116987091B (zh) 用于治疗癫痫发作疾病的药物及其制备方法
US12564580B2 (en) Mitochondria-targeted isoketal/isolevuglandin scavengers and uses thereof
KR101840178B1 (ko) 〔２.２.２〕비시클릭 유도체 및 사용방법
CN119731174A (zh) 取代的咪唑并[1,2-a]吡啶化合物及其在治疗和预防纤维化中的用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant